These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15215557

  • 1. New generation of valproic acid.
    Trojnar MK, Wierzchowska-Cioch E, Krzyzanowski M, Jargiełło M, Czuczwar SJ.
    Pol J Pharmacol; 2004; 56(3):283-8. PubMed ID: 15215557
    [Abstract] [Full Text] [Related]

  • 2. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?
    Isoherranen N, Yagen B, Bialer M.
    Curr Opin Neurol; 2003 Apr; 16(2):203-11. PubMed ID: 12644750
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic and pharmacodynamic analysis of (E)-2-ene valproyl derivatives of glycine and valproyl derivatives of nipecotic acid.
    Bialer M, Kadry B, Abdul-Hai A, Haj-Yehia A, Sterling J, Herzig Y, Shirvan M.
    Biopharm Drug Dispos; 1996 Oct; 17(7):565-75. PubMed ID: 8894115
    [Abstract] [Full Text] [Related]

  • 4. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice.
    Okada A, Onishi Y, Yagen B, Shimshoni JA, Kaufmann D, Bialer M, Fujiwara M.
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain.
    Winkler I, Sobol E, Yagen B, Steinman A, Devor M, Bialer M.
    Neuropharmacology; 2005 Dec; 49(8):1110-20. PubMed ID: 16055160
    [Abstract] [Full Text] [Related]

  • 6. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ.
    Drugs Aging; 2003 Dec; 20(2):141-52. PubMed ID: 12534314
    [Abstract] [Full Text] [Related]

  • 7. Disposition of valpromide, valproic acid, and valnoctamide in the brain, liver, plasma, and urine of rats.
    Blotnik S, Bergman F, Bialer M.
    Drug Metab Dispos; 1996 May; 24(5):560-4. PubMed ID: 8723737
    [Abstract] [Full Text] [Related]

  • 8. New antiepileptic drugs that are second generation to existing antiepileptic drugs.
    Bialer M.
    Expert Opin Investig Drugs; 2006 Jun; 15(6):637-47. PubMed ID: 16732716
    [Abstract] [Full Text] [Related]

  • 9. Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid.
    Shimshoni JA, Yagen B, Pessah N, Wlodarczyk B, Finnell RH, Bialer M.
    Epilepsia; 2008 Jul; 49(7):1202-12. PubMed ID: 18435754
    [Abstract] [Full Text] [Related]

  • 10. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid.
    Shimshoni JA, Bialer M, Wlodarczyk B, Finnell RH, Yagen B.
    J Med Chem; 2007 Dec 13; 50(25):6419-27. PubMed ID: 17994680
    [Abstract] [Full Text] [Related]

  • 11. Valproic Acid: second generation.
    Bialer M, Yagen B.
    Neurotherapeutics; 2007 Jan 13; 4(1):130-7. PubMed ID: 17199028
    [Abstract] [Full Text] [Related]

  • 12. Initiation of treatment and selection of antiepileptic drugs in childhood epilepsy.
    Oka E, Murakami N, Ogino T, Kobayashi K, Ohmori I, Akiyama T, Ito M.
    Epilepsia; 2004 Jan 13; 45 Suppl 8():17-9. PubMed ID: 15610189
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain.
    Winkler I, Blotnik S, Shimshoni J, Yagen B, Devor M, Bialer M.
    Br J Pharmacol; 2005 Sep 13; 146(2):198-208. PubMed ID: 15997234
    [Abstract] [Full Text] [Related]

  • 15. Structure-function studies for the panacea, valproic acid.
    Terbach N, Williams RS.
    Biochem Soc Trans; 2009 Oct 13; 37(Pt 5):1126-32. PubMed ID: 19754465
    [Abstract] [Full Text] [Related]

  • 16. Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamide.
    Sobol E, Yagen B, Lamb JG, White HS, Wlodarczyk BJ, Finnell RH, Bialer M.
    Epilepsy Res; 2007 Jan 13; 73(1):75-84. PubMed ID: 16997532
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DP-VPA D-Pharm.
    Labiner DM.
    Curr Opin Investig Drugs; 2002 Jun 13; 3(6):921-3. PubMed ID: 12137414
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the anticonvulsant, behavioral and pharmacokinetic interaction profiles of stiripentol in combination with clonazepam, ethosuximide, phenobarbital, and valproate using isobolographic analysis.
    Luszczki JJ, Ratnaraj N, Patsalos PN, Czuczwar SJ.
    Epilepsia; 2006 Nov 13; 47(11):1841-54. PubMed ID: 17116023
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D, Suwanmanee J, Visudtibhan A.
    Am J Ther; 2006 Nov 13; 13(3):211-7. PubMed ID: 16772762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.